Proactive Investors - Run By Investors For Investors

Holista CollTech secures rights to ‘botox-like’ skin product

Holista CollTech secures rights to ‘botox-like’ skin product

Holista Colltech (ASX:HCT) has secured the exclusive rights for the Geltox Skin Science formulation that provides immediate short term reduction in facial expression lines as well as wrinkles.

This also reduces the appearance of these lines over the course of several months while eliminating the need for injections by a qualified professional.

Geltox Skin Science uses a combination of peptides and muscle relaxers that deeply penetrate skin and cause mild paralysis in select areas of the face similar to injections like Botox.

The technology is patent pending and was developed by Palma Biotech.

Holista will take the formulation into the Asian Pacific region.


Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.

View full HCT profile View Profile

Holista Colltech Ltd Timeline

September 19 2017

Related Articles

October 18 2018
Sativa Investments has taken a big step towards becoming the UK's first seed to consumer medicinal cannabis business
Proton Therapy sign
October 10 2018
The broker says the cancer treatment developer could potentially take the entire share of the growth market from ageing cyclotron companies
myLotus testing kit
October 31 2018
The launch at the Fertility Show in London at the start of November is the first step in a switch in focus brought about by new executive chairman Matthew Walls

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use